Get the Stockscreener App
2.34
5.31%
-0.11
Clearmind Medicine Inc stock is traded at $2.34, with a volume of 53,247.
It is down -5.31% in the last 24 hours and down -14.71% over the past month.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.
See More
Previous Close:
$2.45
Open:
$2.42
24h Volume:
53,247
Relative Volume:
0.14
Market Cap:
$3.51M
Revenue:
-
Net Income/Loss:
$-6.78M
P/E Ratio:
-0.0548
EPS:
-42.6996
Net Cash Flow:
$-4.67M
1W Performance:
-4.53%
1M Performance:
-14.71%
6M Performance:
-94.03%
1Y Performance:
-96.21%
1-Day Range:
$2.265
$2.50
1-Week Range:
$2.07
$2.64
52-Week Range:
$1.743
$62.80
Clearmind Medicine Inc Stock (CMND) Company Profile
Compare CMND with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CMND
Clearmind Medicine Inc
|
2.34 | 3.67M | 0 | -6.78M | -4.67M | -42.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
443.56 | 114.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
744.77 | 79.26B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
810.09 | 49.47B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
363.76 | 48.47B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.35 | 38.37B | 4.98B | 69.59M | 525.67M | 0.5197 |
Clearmind Medicine Inc Stock (CMND) Latest News
Clearmind completes treatment for second cohort in AUD drug trial By Investing.com - Investing.com Nigeria
Clearmind announces completion of treatment for second cohort in CMND-100 trial - TipRanks
Clearmind Completes Treatment In 2nd Cohort Of CMND-100 Phase I/IIa Trial In Alcohol Use Disorder - Nasdaq
Clearmind Medicine IncTopline results from second cohort of CMND-100 expected in coming months - marketscreener.com
Clearmind Medicine Inc. Completes Treatment for Second Cohort in Phase I/IIa Trial of CMND-100 for Alcohol Use Disorder - Quiver Quantitative
Clearmind Medicine Announces Successful Completion of Treatment in All Patients of the Second Cohort in Ongoing Phase I/IIa Clinical Trial for CMND-100 - The Manila Times
6 patients finish Clearmind trial testing new alcohol use disorder drug - Stock Titan
Will Clearmind Medicine Inc. outperform tech stocks2025 Trading Recap & Stepwise Trade Signal Implementation - bollywoodhelpline.com
Aug Final Week: Does Clearmind Medicine Inc stock trade at a discount to peersJuly 2025 Rallies & Free Fast Entry Momentum Trade Alerts - Bộ Nội Vụ
Risk On: Is Clearmind Medicine Inc a potential multi bagger2025 Valuation Update & Safe Entry Zone Tips - baoquankhu1.vn
Why Clearmind Medicine Inc. stock remains on buy listsTrail vs Road Selection & compare fit, width, and feel - Улправда
Will Clearmind Medicine Inc. stock deliver shareholder value2025 Breakouts & Breakdowns & Weekly Top Gainers Alerts - ulpravda.ru
Published on: 2026-01-09 01:57:04 - Улправда
Does Clearmind Medicine Inc. (CWY0) stock trade below intrinsic valueQuarterly Investment Review & Scalable Portfolio Growth Methods - Улправда
Will Clearmind Medicine Inc. stock benefit from AI adoptionStock Buy Signals & Target Triple-Digit Stock Opportunities - ulpravda.ru
Surprises Report: Why Clearmind Medicine Inc stock is recommended by analystsChart Signals & Safe Swing Trade Setups - Bộ Nội Vụ
How geopolitical tensions affect Clearmind Medicine Inc. stock2026 world cup usa national team group stage defensive leaders possession football match prediction insights - Улправда
Why retail traders accumulate Clearmind Medicine Inc. (CWY0) stockStop Loss Placement Tips & Build Wealth With Zero-Cost Tools - bollywoodhelpline.com
Portfolio Shifts: Why Clearmind Medicine Inc stock is recommended by analystsRate Cut & Reliable Price Action Trade Plans - moha.gov.vn
Clearmind Medicine (CMND) Stock Analysis Report | Financials & Insights - Benzinga España
Clearmind Medicine Announces the Notice of an International Patent App... - Moscow-Pullman Daily News
Clearmind Medicine regains compliance with NASDAQ minimum bid price rule - MSN
Clearmind regains Nasdaq compliance as shares maintain $1 minimum By Investing.com - Investing.com Nigeria
Clearmind regains Nasdaq compliance as shares maintain $1 minimum - Investing.com India
Clearmind Medicine Says Nasdaq Compliance Regained on Minimum Bid Price Rule - MarketScreener
Clearmind Medicine regains compliance with Nasdaq minimum bid price rule - TipRanks
Clearmind Medicine Inc. Regains Compliance with Nasdaq Listing Requirements - Quiver Quantitative
Clearmind Medicine Regains Compliance with Nasdaq Minimum Bid Price Requirement - marketscreener.com
Clearmind Medicine highlights key 2025 achievements - MSN
Clearmind advances AUD treatment as phase I/IIa trial progresses By Investing.com - Investing.com Australia
Clearmind advances AUD treatment as phase I/IIa trial progresses - Investing.com
Clearmind Medicine Inc. Reflects on Major Progress in 2025 Clinical Trials for CMND-100 Targeting Alcohol Use Disorder - Quiver Quantitative
Clearmind Medicine Reflects on a Transformative 2025: Key Clinical Advancements, Expanded Global Reach, and Strengthened Foundation for Future Growth - Yahoo Finance
Psychedelic: Clearmind completes second cohort enrollment for CMND-100 trial - MSN
About Us - FinancialContent
Cash from operating activities of Clearmind Medicine Inc. – MUN:CWY - TradingView — Track All Markets
Trading Recap: How strong is Clearmind Medicine Inc. stock balance sheetJuly 2025 Selloffs & Weekly Setup with ROI Potential - moha.gov.vn
How interest rate cuts could boost Clearmind Medicine Inc. stock2025 Geopolitical Influence & Short-Term High Return Ideas - Улправда
Clearmind Medicine Inc. (NASDAQ: CMND)Share Price - intelligentinvestor.com.au
Published on: 2025-12-19 05:54:25 - Улправда
Pretax income of Clearmind Medicine Inc. – LS:A41YK5 - TradingView — Track All Markets
Clearmind Medicine completes second cohort enrollment in Phase I/IIa AUD trial - MSN
Free float of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Cash from financing activities of Clearmind Medicine Inc. – FWB:CWY - TradingView — Track All Markets
Cost of goods sold of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Gross profit of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
EBIT of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
EBIT per share of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Diluted earnings per share (diluted EPS) of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Long term debt to total assets ratio of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Basic earnings per share (basic EPS) of Clearmind Medicine Inc. – LSX:A41YK5 - TradingView — Track All Markets
Clearmind Medicine Inc Stock (CMND) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.70%
0.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):